Search results for 'triple-negative breast cancer'

Search results for "triple-negative breast cancer"

Study reveals a therapeutic vulnerability in aggressive subtype of triple-negative breast cancer

A new study published today in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center details a therapeutic vulnerability in patients with an aggressive subtype of triple-negative breast cancer. Read more

Medical News - Dec 27

Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancer

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows quickly, spreads early and lacks the hormone receptors that make other breast cancers treatable with targeted therapies. Read more

Medical News - Dec 05

Novel therapy reduces tumor growth in models of triple-negative breast cancer

Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of the disease. Read more

Medical News - Nov 18

First-line (1L) datopotamab deruxtecan (Dato-DXd) vs chemotherapy in patients with locally recurrent inoperable or metastatic triple-negative breast cancer (mTNBC) for whom immunotherapy was not an option: Primary results from the randomised, phase 3 TROPION-Breast02 trial

Onclive - Nov 14

STAT+: At ESMO, AstraZeneca, Gilead square off in triple-negative breast cancer

AstraZeneca and Gilead both reported successful trials in a hard-to-treat form of breast cancer, sparking a debate about which drug may be better. Read more

Stat - Oct 19

Browse the latest triple-negative breast cancer news online for free